1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer Incidence and mortality worldwide: IARC Cancer Base No. 11, Lyon, France, 2013. http://globocan.iarc.fr/.
2. Epidemiology and risk factors of urothelial bladder cancer;Burger;Eur Urol,2013
3. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013;Babjuk;Eur Urol,2013
4. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder;Lamm;N Engl J Med,1991
5. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials;Sylvester;J Urol,2004